Skip to main content
Registrieren
Springer Medizin Österreich
SUCHE
MENÜ 1 2 3 4
main-content
nach oben

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: Wiener klinische Wochenschrift 1-2/2017

01.01.2017 | original article

Cilastatin does not affect Carba NP test performance for detection of carbapenemase production in Enterobacteriaceae

verfasst von: Dr. Rainer Hartl, Sarah Widhalm, Dr. Heidrun Kerschner, Univ. Prof. Petra Apfalter, Dr. Rainer Gattringer

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 1-2/2017

Einloggen, um Zugang zu erhalten
share
TEILEN

Summary

The Carba NP test is a simple confirmation method for carbapenemase-producing Enterobacteriaceae (CPE) but reagents have to be freshly prepared as imipenem sodium salt is unstable. We evaluated the Carba NP test performance based on a commercially available 10-fold cheaper drug formulation containing cilastatin against 217 CPE and 78 non-CPE isolates with reduced meropenem susceptibility. Specificity and sensitivity were 100 % and 98.6 %, respectively and 3 false negative results of blaVIM-1-producing Proteus mirabilis were reproducible with the RAPIDEC® Carba NP test. Cilastatin does not disturb test performance provided that the imipenem drug quantity is doubled.
Vorheriger Artikel Determinants of maternal vitamin D concentrations in Slovenia
Nächster Artikel Pretransplantation monitoring of HLA antibodies by complement dependent cytotoxicity and Luminex-based assays
Literatur
1.
Nordmann P, Dortet L, Poirel L. Carbapenem resistance in enterobacteriaceae: Here is the storm! Trends Mol Med. 2012;18:263–72. CrossRefPubMed
2.
Grundmann H, Livermore DM, Giske CG, et al. Carbapenem-non-susceptible enterobacteriaceae in Europe: conclusions from a meeting of national experts. Euro Surveill. 2010;15(46):pii=19711.
3.
Tacconelli E, Cataldo MA, Dancer SJ, et al. Escmid guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant gram-negative bacteria in hospitalized patients. Clin Microbiol Infect. 2014;20(Suppl):1–55. CrossRefPubMed
4.
Nordmann P, Poirel L. The difficult-to-control spread of carbapenemase producers among enterobacteriaceae worldwide. Clin Microbiol Infect. 2014;20:821–30. CrossRefPubMed
5.
6.
Tijet N, Boyd D, Patel SN, Mulvey MR, Melano RG. Evaluation of the carba np test for rapid detection of carbapenemase-producing enterobacteriaceae and pseudomonas aeruginosa. Antimicrob Agents Chemother. 2013;57:4578–80. CrossRefPubMedPubMedCentral
7.
8.
Dortet L, Brechard L, Poirel L, Nordmann P. Impact of the isolation medium for detection of carbapenemase-producing enterobacteriaceae using an updated version of the carba np test. J Med Microbiol. 2014;63:772–6. CrossRefPubMed
9.
Giske CG, Gezelius L, Samuelsen O, Warner M, Sundsfjord A, Woodford N. A sensitive and specific phenotypic assay for detection of metallo-beta-lactamases and kpc in klebsiella pneumoniae with the use of meropenem disks supplemented with aminophenylboronic acid, dipicolinic acid and cloxacillin. Clin Microbiol Infect. 2011;17:552–6. CrossRefPubMed
10.
Naas T, Cuzon G, Bogaerts P, Glupczynski Y, Nordmann P. Evaluation of a DNA microarray (check-mdr ct102) for rapid detection of tem, shv, and ctx-m extended-spectrum beta-lactamases and of kpc, oxa-48, vim, imp, and ndm-1 carbapenemases. J Clin Microbiol. 2011;49:1608–13. CrossRefPubMedPubMedCentral
11.
Dallenne C, Da Costa A, Decre D, Favier C, Arlet G. Development of a set of multiplex pcr assays for the detection of genes encoding important beta-lactamases in enterobacteriaceae. J Antimicrob Chemother. 2010;65:490–5. CrossRefPubMed
12.
Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex pcr for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 2011;70:119–23. CrossRefPubMed
13.
Vasoo S, Cunningham SA, Kohner PC, et al. Comparison of a novel, rapid chromogenic biochemical assay, the carba np test, with the modified hodge test for detection of carbapenemase-producing gram-negative bacilli. J Clin Microbiol. 2013;51:3097–101. CrossRefPubMedPubMedCentral
14.
Keynan S, Hooper NM, Felici A, Amicosante G, Turner AJ. The renal membrane dipeptidase (dehydropeptidase i) inhibitor, cilastatin, inhibits the bacterial metallo-beta-lactamase enzyme cpha. Antimicrob Agents Chemother. 1995;39:1629–31. CrossRefPubMedPubMedCentral
15.
Adler A, Assous MV, Paikin S, et al. Emergence of vim-producing aeromonas caviae in israeli hospitals. J Antimicrob Chemother. 2014;69(5):1211–4. CrossRefPubMed
16.
17.
Dortet L, Poirel L, Errera C, Nordmann P. Carbacineto np test for rapid detection of carbapenemase-producing acinetobacter spp. J Clin Microbiol. 2014;52:2359–64. CrossRefPubMedPubMedCentral
Metadaten
Titel
Cilastatin does not affect Carba NP test performance for detection of carbapenemase production in Enterobacteriaceae
verfasst von
Dr. Rainer Hartl
Sarah Widhalm
Dr. Heidrun Kerschner
Univ. Prof. Petra Apfalter
Dr. Rainer Gattringer
Publikationsdatum
01.01.2017
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 1-2/2017
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-016-1106-6

Weitere Artikel der Ausgabe 1-2/2017

Wiener klinische Wochenschrift 1-2/2017 Zur Ausgabe

original article

Pretransplantation monitoring of HLA antibodies by complement dependent cytotoxicity and Luminex-based assays

original article

No common understanding of profession terms utilized in health services research

original article

Determinants of maternal vitamin D concentrations in Slovenia

MUW

MUW Researcher of the Month Jänner 2017

original article

Prescription of oral antidiabetic drugs in Tyrol – Data from the Tyrol diabetes registry 2012–2015

short report

The medical and scientific responsibility of pollen information services

Version: 0.2064.0